1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 16 NOVEMBER 2015

CNS Drug News 16 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Abuse-Deterrent Formulations Will Not Curb Opioid Abuse Alone
Industry Brief - NeuroDerm Modifies ND0612H/ND0612L US Development Plan In PD
Industry Trend Analysis - Early Success No Guarantee Of ANAVEX 2-73' Commercial Potential
Industry Brief - Lupin Gains US Donepezil Approval
Industry Brief - ProMIS Acquires Worldwide Licence To Collective Coordinates
Industry Trend Analysis - Avanir Will Focus On Agitation In Alzheimer's Disease Symptoms
Industry Brief - Neos Receives Cotempla CRL From FDA
Industry Trend Analysis - Encenicline Back On Course For 2016 NDA
Industry Trend Analysis - Shire Shifting Focus To Rare Diseases
Industry Brief - FDA Grants Fast Track Designation For CAM2038 Long-Acting Buprenorphine Injectables
Industry Brief - IntelGenx/RedHill Receive First European Marketing Approval For Rizaport
Industry Trend Analysis - FDA's Tentative Approval Of Xtampza ER Will Further Delay Launch
Industry Brief - Glenmark Gains Tentative Lacosamide Approval
Industry Brief - Court Delivers Palonosetron Blow To Teva
Industry Brief - FDA Grants Breakthrough Therapy Designation To Teva's SD-809 For TD
Industry Trend Analysis - Unanimous Approval Will Put Merck's Bridion Back On Track For US Indication
Industry Brief - Knight Gains Commercial Rights To Antibe's Anti-Inflammatory And Pain Drugs
Industry Brief - CNS Conferences - February 2016

Table Of Contents

CNS Drug News 16 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.